Article Details
Retrieved on: 2022-02-21 07:24:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
By Jaime Llinares Taboada AstraZeneca PLC on Monday reported positive Phase 3 trial results for its Enhertu treatment on breast cancer patients.
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here